October Pharma S.A.E (EGX:OCPH)

Market Cap	2.40B
Revenue (ttm)	1.41B
Net Income (ttm)	141.29M
Shares Out	12.00M
EPS (ttm)	11.77
PE Ratio	16.96
Forward PE	n/a
Dividend	2.50 (1.24%)
Ex-Dividend Date	n/a

Volume	5,206
Average Volume	24,482
Open	201.51
Previous Close	201.51
Day's Range	198.00 - 205.80
52-Week Range	87.32 - 249.88
Beta	0.17
RSI	49.96
Earnings Date	Nov 12, 2025

About October Pharma S.A.E

October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides its products in solid forms, such as tablets, capsules, and powders; liquid forms comprising syrups, drops, solutions, and sprays; creams and suppositories; soft gelatin capsules; and ampoules and vials. October Pharma S.A.E was founded in 1987 is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: OCPH

Financial Performance

In 2024, October Pharma S.A.E's revenue was 1.23 billion, an increase of 21.39% compared to the previous year's 1.01 billion. Earnings were 131.26 million, a decrease of -12.72%.